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Abstract
The E. coli AntiMicrobial Satellite (EcAMSat) mission will investigate space microgravity effects on
the dose-dependent antibiotic response and resistance of wildtype and mutant strains of uropathogenic
Escherichia coli, a bacterial pathogen responsible for urinary tract infection in humans and animals.
EcAMSat is the first biological science CubeSat built by NASA in the 6U configuration, and it will
feature the fifth biological CubeSat payload developed by the NASA/Ames Research Center and the
fourth mission to conduct a peer-reviewed biological science experiment. Building on the hardware
flight heritage of GeneSat, PharmaSat-1, and O/OREOS, EcAMSat features a fluidics payload that can
create and precisely administer 4 concentrations of antibiotic solution to microwell-dwelling cultures of
E. coli. It measures the time-dependent metabolic activity of the bacterial cultures, as well as their
optical densities, using a dedicated 3-color LED-based absorbance monitoring system for each of the 48
microwells. We will report payload laboratory characterization results and preparation of the EcAMSat
spacecraft for spaceflight in the coming year.
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Introduction

The EcAMSat mission was started as a NASA Ames Mission of Opportunity (MoO-1), selected under the
Stand Alone Missions of Opportunity (SALMON) Announcement of Opportunity (AO). The mission was
designed to take advantage of off the shelf hardware with flight heritage on several previous flight projects
to provide an increased value return on investment. The existing flight backup hardware for the PharmaSat
mission was utilized to construct the flight unit and spares for EcAMSat, with only some small modifications
to the spacecraft electronics, and an adaptation of the structural elements to adapt to the 6U spacecraft formfactor. EcAMSat is classified as Class D Prototype Payload Hardware as per NASA Procedural Requirement
(NPR) 8705.4, which enabled a rapid and low cost development, owed in part to increased risk tolerance.
While EcAMSat is currently not manifested for a launch, flight hardware is complete and a launch is
expected in the 2014 to 2016 timeframe. [3]

Figure 1: EcAMSat CAD model
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The 6U Structure

NASA Ames 6U architecture shown in Figure 2 was designed around the intent to fly up to three different
payloads: two 2U payloads and one 0.5U payload. The remainder of the 6U spacecraft volume is utilized
with a heritage nanosat bus and a Payload Interface Board allowing the bus to accept additional inputs
from extra payloads and solar panels. Future bus development could allow for increased payload volume
through integration of the Payload Interface Board into the spacecraft bus. Due to budgetary constraints
and limited launch access, only the EcAMSat payload was selected for this flight. The remaining volume
has been utilized with ballast/balance mass and increased attitude control.
Launch availability has been reduced due to the size and lack of maturation in launch capabilities for
the 6U (1x 2x 3U) form-factor. As such, only low-altitude deployments have been presented, meaning mass
must be increased (for the same outer dimensions) to lengthen orbit lifetime. An increase in mass, however,
comes with its own cost: an increased moment of inertia, as a result the previous attitude control system
will take longer to stabilize. EcAMSat must quickly stabilize to meet micro-g requirements before starting
its experiment and must remain stable to maximize radio contact duration during low-altitude disturbances.
These stability objectives required precision center-of-mass measurements (to reduce disturbance torques)
and an increase in attitude control (to counteract disturbance torques). Engineers sought to maximize mass
and precisely locate center of mass by placing stainless steel plates in unused payload volumes. Additional
hysteresis rods and permanent magnets were added to reduce post-launch stabilization duration and increase
radio pointing accuracy.
EcAMSat reduced costs by creating a 6U spacecraft comprised largely of previously built, heritage 3U
spacecraft hardware. The only new components and assemblies required to create EcAMSat were modified
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Figure 2: Top down view of structure, solar panels removed
cable assemblies (many just lengthened to accommodate the increased spacecraft dimensions), the Payload
Interface Board (to increase spacecraft bus capabilities), and mechanical structure to hold what is essentially
two 3U spacecraft together. This structure includes solar panel attachment panels (purple, center), auxiliary
payload closeout panel (green, left end), and payload closeout panel (teal, right end). To ease assembly
and integration, as well as simplify deployment pusher systems, the bus closeout panel (blue, left end) has
volume to house the S-band radio antenna cable and umbilical cable connector. The aforementioned auxiliary
payload closeout panel houses the beacon radio and provides a mounting location for the whip antenna.
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Scientific Payload

The EcAMSat mission is a re-flight of the PharmaSat hardware flown in 2009. The major biological change
from PharmaSat to EcAMSat was replacing yeast with E. Coli. The change in biological organism from
eukaryote to bacteria allow for the testing of the antibiotic Gentamicin on wild type Uropathogenic E. coli
(UPEC) and a gene knock out mutant.
To accommodate the differing biology, the fluidic system had to be altered. Fluidic cards used to house
the biology and direct fluid flow were changed to have smaller filter sizes (.2 m from 1.2 m) to prevent cell
escape. Temperature was changed to accommodate E. Coli from (27C to 37C) which required higher power
supply. The original 3U design was converted to 6U to support the additional solar panels needed to provide
more power for the heaters. Valves, plumbing and pumping phases were changed to accommodate differing
experimental requirements.
For further information about the functionality of the PharmaSat payload system, there are several
publications which explain the fluidics system in high detail [1, 2].
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Software

EcAMSat was developed using a legacy codebase from the previous PharmaSat mission. The flight software
consists of 3 firmware packages: Bus, Payload, and Fluidics. Each of these packages was developed in a C
environment.
The Bus software provides control, monitoring, commanding and communications of Bus operations
during phases of mission operations. The bus software also provides some services to the payload systems,
such as data storage and communications routing.
EcAMSat contains one payload with two microcontrollers, each with their own distinct effort. The payload
software effort provides control of the fight experiment, flight experiment sequencing, temperature control,
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Figure 3: PharmaSat derived payload
data sampling, and data storage of the experiment during the Mission. The payload firmware package was
heavily rewritten from the PharmaSat code with new experiment phases and different temperature settings.
The fluidics firmware package provides control over the pumps and valves systems. Given, the new fluidic
system design, the software was completely rewritten to accommodate new flow speeds, anti-biotic mixing,
bag volumes, and pump frequencies.
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The Future of EcAMSat

At the time of writing this paper, EcAMSat is currently not manifested for launch, due to the launch
availability issues discussed in Section 2. The flight unit has completed proto-qualification shock and
vibration tests, along with center of gravity balancing. Once a launch is manifested, a thermal-vacuum
and power management test can be conducted to assess system environmental performance in the expected
orbital conditions.

Figure 4: EcAMSat FLT-1 undergoing mass properties evaluation
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